Your browser doesn't support javascript.
loading
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Sahin, Ugur; Muik, Alexander; Derhovanessian, Evelyna; Vogler, Isabel; Kranz, Lena M; Vormehr, Mathias; Baum, Alina; Pascal, Kristen; Quandt, Jasmin; Maurus, Daniel; Brachtendorf, Sebastian; Lörks, Verena; Sikorski, Julian; Hilker, Rolf; Becker, Dirk; Eller, Ann-Kathrin; Grützner, Jan; Boesler, Carsten; Rosenbaum, Corinna; Kühnle, Marie-Cristine; Luxemburger, Ulrich; Kemmer-Brück, Alexandra; Langer, David; Bexon, Martin; Bolte, Stefanie; Karikó, Katalin; Palanche, Tania; Fischer, Boris; Schultz, Armin; Shi, Pei-Yong; Fontes-Garfias, Camila; Perez, John L; Swanson, Kena A; Loschko, Jakob; Scully, Ingrid L; Cutler, Mark; Kalina, Warren; Kyratsous, Christos A; Cooper, David; Dormitzer, Philip R; Jansen, Kathrin U; Türeci, Özlem.
Affiliation
  • Sahin U; BioNTech, Mainz, Germany. ugur.sahin@biontech.de.
  • Muik A; TRON gGmbH-Translational Oncology at the University Medical Center of the Johannes Gutenberg, Mainz, Germany. ugur.sahin@biontech.de.
  • Derhovanessian E; BioNTech, Mainz, Germany.
  • Vogler I; BioNTech, Mainz, Germany.
  • Kranz LM; BioNTech, Mainz, Germany.
  • Vormehr M; BioNTech, Mainz, Germany.
  • Baum A; BioNTech, Mainz, Germany.
  • Pascal K; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Quandt J; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Maurus D; BioNTech, Mainz, Germany.
  • Brachtendorf S; BioNTech, Mainz, Germany.
  • Lörks V; BioNTech, Mainz, Germany.
  • Sikorski J; BioNTech, Mainz, Germany.
  • Hilker R; BioNTech, Mainz, Germany.
  • Becker D; BioNTech, Mainz, Germany.
  • Eller AK; BioNTech, Mainz, Germany.
  • Grützner J; BioNTech, Mainz, Germany.
  • Boesler C; BioNTech, Mainz, Germany.
  • Rosenbaum C; BioNTech, Mainz, Germany.
  • Kühnle MC; BioNTech, Mainz, Germany.
  • Luxemburger U; BioNTech, Mainz, Germany.
  • Kemmer-Brück A; BioNTech, Mainz, Germany.
  • Langer D; BioNTech, Mainz, Germany.
  • Bexon M; BioNTech, Mainz, Germany.
  • Bolte S; Bexon Clinical Consulting, Upper Montclair, NJ, USA.
  • Karikó K; BioNTech, Mainz, Germany.
  • Palanche T; BioNTech, Mainz, Germany.
  • Fischer B; BioNTech, Mainz, Germany.
  • Schultz A; BioNTech, Mainz, Germany.
  • Shi PY; CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany.
  • Fontes-Garfias C; University of Texas Medical Branch, Galveston, TX, USA.
  • Perez JL; University of Texas Medical Branch, Galveston, TX, USA.
  • Swanson KA; Pfizer, Pearl River, NY, USA.
  • Loschko J; Pfizer, Pearl River, NY, USA.
  • Scully IL; Pfizer, Pearl River, NY, USA.
  • Cutler M; Pfizer, Pearl River, NY, USA.
  • Kalina W; Pfizer, Pearl River, NY, USA.
  • Kyratsous CA; Pfizer, Pearl River, NY, USA.
  • Cooper D; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Dormitzer PR; Pfizer, Pearl River, NY, USA.
  • Jansen KU; Pfizer, Pearl River, NY, USA.
  • Türeci Ö; Pfizer, Pearl River, NY, USA.
Nature ; 586(7830): 594-599, 2020 10.
Article in En | MEDLINE | ID: mdl-32998157

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Th1 Cells / Antibodies, Viral Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Nature Year: 2020 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Th1 Cells / Antibodies, Viral Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Nature Year: 2020 Document type: Article Affiliation country: Germany